期刊文献+

甲基磺酸催化合成苯甲醛VC缩醛的研究 被引量:4

Study on catalytic synthesis of benzylaldehyde L-ascorbic acid acetal by methyl sulfonic acid
在线阅读 下载PDF
导出
摘要 以苯甲醛与VC为原料,N,N-二甲基乙酰胺为溶剂,甲基磺酸为催化剂,环己烷为带水剂,合成了苯甲醛VC缩醛。考察了原料配比、催化剂用量、溶剂用量、回流温度对反应收率的影响。最佳条件为:苯甲醛、VC与甲基磺酸的物质的量的比为1∶1.5∶0.25(摩尔比),溶剂用量0.75 L,回流温度120℃,反应时间4.0 h。产物结构用IR、熔点测定和元素分析确认。 Benzylaldehyde L-ascorbic acid acetal was synthesized using benzylaldehyde and L-ascorbic acid as raw materials and dimethyl acetamide as solvent and methyl sulfonic acid as catalyst and the eyclohexane as dehydrating agent. Factors influencing the yield were investigated. The optimum reaction conditions are as follows : benzylaldehyde : L-ascorbic acid : methyl sulfonic acid is 1 : 1.5 :0. 25, amount of solvent is 0.75 L, reflux temperature is 120 ℃, reaction time is 4 h. The title compound was characterized by IR, MS and elemental analysis.
出处 《应用化工》 CAS CSCD 2009年第6期840-841,846,共3页 Applied Chemical Industry
关键词 甲基磺酸 催化 合成 苯甲醛VC缩醛 methyl sulfonic acid catalysis synthesis benzylaldehyde L-ascorbie acid aeetal
  • 相关文献

参考文献8

  • 1何莉斌,宁正祥,李娜.甲氧羰基丙烯酸-6-L抗坏血酸酯的合成及抗氧化活性研究[J].食品工业科技,2009,30(2):265-267. 被引量:4
  • 2无可克.功能性化妆品[M].北京:化学工业出版社,2006:38-40.
  • 3高荫榆,雷占兰,谢何融,郭磊.L-抗坏血酸棕榈酸酯的抗氧化效果研究[J].食品科学,2007,28(11):60-62. 被引量:28
  • 4郑大贵,余衍文,朱华龙,叶红德.辛醛VC缩醛的合成及其在茶籽油中的抗氧化性能[J].化学研究与应用,2008,20(3):356-359. 被引量:4
  • 5Motoyoshi K,Suzuki T.Cosmetics containing novel ascorbic derivatives:JP,08269074[P].1996-10-15.
  • 6Mouhtady O,Gaspard-Houghmane H,Roques N,et al.Metal triflates-methanesufonic acid as new catalytic systems application to the Fries rearrangement[J].Tetrahedron Lett,2003,44:6379-6382.
  • 7Scrivanti A,Beghetto V,Zanato M,et al.Carbonylation of terminal aldynes catalysed by Pd complexes in combination with tri(2-furyl)phosphine and methanesulfonic acid[J].J Mol Catal A:Chem,2000,160:331-336.
  • 8Luong B X,Petre A L,Hoelderich W F,et al.Use methanesulfonic acid as catalyst for the production linear alkylbenzenes[J].J Catal,2004,226:301-307.

二级参考文献24

共引文献32

同被引文献24

  • 1刘美艳,俞善信,管仕斌.对甲苯磺酸催化合成癸二酸二乙酯[J].海南师范学院学报(自然科学版),2005,18(2):162-163. 被引量:5
  • 2Kim D K, Kim H T, Cho Y B,et al. Antlcaneer activity of cismalonato [ ( 4R, 5R ) -4, 5-bis ( aminomethyl ) -2-isopropyl-1, 3- dioxoane] platinum ( Ⅱ ), a new platinum analogue, as an antieaneer agent [ J ]. Cancer C hemother Pharmacol, 1995,44 (5) : 441 -445.
  • 3Hong W S, Kim H T, Kim K H, et al. In vitro antitumor activity of a new platinum complex, cis-malonato [ (4R, 5R )-4, 5-bis ( aminomethyl ) -2-isopropyl-1, 3-dioxoane ] platinum ( Ⅱ) ( SKI 2053R) ,against human stomach and lung cancer cell lines [ J]. Anticancer Res, 1995,15 ( 1 ) :51 - 54.
  • 4Choi C H,Cha Y J,An C S,et al. Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein [ J ]. Cancer Cell International, 2004,4(6) :1 - 12.
  • 5Lee W S, Lee G W, K H W, et al. A phase Ⅱ trial of heptaplatin/ 5-FU and leucovorin for advanced stomach cancer [ J ]. Cancer Research and Treatment, 2005,37 (4) : 208 - 211.
  • 6Min Y J,Bang S J,Shin J W,et al. Combination chemotherapy with 5-fluorouracil and heptaplatin as first-line treatment in patients with advanced gastric cancer[ J ]. J Korean Med Sci ,2004,19 (3) : 369 - 373.
  • 7Kim D K, Kim G, Gam J, et al. Synthesis and antitumor activity of a series of [ 2-substituted-4,5-bis ( aminomethyl ) -1,3-dioxolane ] platinum( Ⅱ ) complexes [ J ]. J Med Chem, 1994,37 ( 10 ) : 1471 - 1485.
  • 8Sbovata S M, Bettio F, Mozzon M. Cisplatinum and transplatinum complexes with benzyliminoethcr ligands : synthesis, characterization, structure-activity relationships,and in vitro and in vivo antitumor efficacy [ J ]. J Med Chem, 2007,50 ( 19 ) :4775 - 4784.
  • 9Sheldrick G M. SHELX97 : Program for crystal structure refinement [ M ]. Germany : University of Gottingen, 1997.
  • 10王敏,宋志国,姜恒,宫红.甲基磺酸催化合成对叔丁基苯甲酸甲酯的新工艺[J].香料香精化妆品,2007(5):11-13. 被引量:6

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部